Gut treatment – Gut Training http://gut-training.com/ Sat, 08 Jan 2022 00:22:36 +0000 en-US hourly 1 https://wordpress.org/?v=5.8.2 https://gut-training.com/wp-content/uploads/2021/11/profile.png Gut treatment – Gut Training http://gut-training.com/ 32 32 Analysis of the 2021 Inflammatory Bowel Disease Treatment Market Outlook by Major Key Players https://gut-training.com/analysis-of-the-2021-inflammatory-bowel-disease-treatment-market-outlook-by-major-key-players/ Fri, 07 Jan 2022 21:56:24 +0000 https://gut-training.com/analysis-of-the-2021-inflammatory-bowel-disease-treatment-market-outlook-by-major-key-players/ New Jersey, United States, – The Global Inflammatory Bowel Disease Treatment Market report is one of the most comprehensive and significant additions to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Inflammatory Bowel Disease Treatment market. The market analysts who produced the report […]]]>

New Jersey, United States, – The Global Inflammatory Bowel Disease Treatment Market report is one of the most comprehensive and significant additions to the market research archive of Market Research Intellect. Provides detailed research and analysis of the major aspects of the global Inflammatory Bowel Disease Treatment market. The market analysts who produced the report have provided detailed information on key growth drivers, restraints, challenges, trends, and opportunities to provide a comprehensive analysis of the global Inflammatory Bowel Disease Treatment market. Market players can use the analysis of market dynamics to plan effective growth strategies and prepare for future challenges in advance.

Each trend in the global Inflammatory Bowel Disease Treatment market is carefully analyzed and researched by market analysts. Market analysts and researchers have performed an in-depth analysis of the global Inflammatory Bowel Disease Treatment market using research methodologies such as pestle and Porter’s five forces analysis.

They have provided accurate and reliable market data and helpful recommendations with the aim of helping players gain insight into the overall current and future market scenario. The Inflammatory Bowel Disease Treatment report includes in-depth research into potential segments including product types, applications, and end-users, along with their contribution to the overall market size.

Get | Download a sample copy with table of contents, graphics and list of [email protected] https://www.marketresearchintellect.com/download-sample/?rid=234239

The Major Players Covered By Inflammatory Bowel Disease Treatment Markets:

  • Abbvie
  • Inc.
  • Pfizer
  • Inc.
  • Allergan Plc.
  • Shire plc
  • Novartis AG
  • Janssen Biotech
  • Inc. (Johnson & Johnson)
  • Ucb Inc.
  • Biogen Inc.
  • Takeda Pharmaceutical Company Limited.
  • Valeant Pharma International
  • Inc.

Market segmentation of automated drug delivery systems:

The Automated Drug Delivery Systems market report has categorized the market into segments comprising by product type and application. Each segment is evaluated based on share and growth rate. Meanwhile, analysts looked at potential areas that could prove rewarding for builders in the years to come. The regional analysis includes reliable forecast on value and volume, thereby helping market players to acquire in-depth insights into the entire industry.

Inflammatory Bowel Disease Treatment Market Split by Type:

  • Aminosalicyclates
  • Tnf inhibitors
  • Corticosteroids
  • Immunomodulators

Inflammatory Bowel Disease Treatment Market Split By Application:

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

Based on geography: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina and Colombia, etc.), Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, Nigeria and South Africa).

Get | Discount on purchasing this report @ https://www.marketresearchintellect.com/ask-for-discount/?rid=234239

Scope of Inflammatory Bowel Disease Treatment Market Report

Report attribute Details
Market size available for years 2021 – 2028
Reference year considered 2021
Historical data 2015 – 2019
Forecast period 2021 – 2028
Quantitative units Revenue in millions of USD and CAGR from 2021 to 2027
Covered segments Types, applications, end users, etc.
Cover of the report Revenue forecast, company ranking, competitive landscape, growth factors and trends
Regional scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Scope of customization Free customization of reports (equivalent to 8 working days for analysts) with purchase. Add or change the scope of country, region and segment.
Price and purchase options Take advantage of custom shopping options to meet your exact research needs. Explore purchasing options

Key questions answered in the report:

  • What is the growth potential of the Inflammatory Bowel Disease Treatment markets?
  • Which product segment will take the lion’s share?
  • Which regional market will emerge as a precursor in the years to come?
  • Which application segment will grow at a sustained rate?
  • What are the growth opportunities that could emerge in the lock washer industry in the years to come?
  • What are the major challenges that the global inflammatory bowel disease treatment markets may face in the future?
  • Who are the leading companies in the global inflammatory bowel disease treatment market?
  • What are the main trends that are positively impacting the growth of the market?
  • What are the growth strategies considered by the players to maintain their grip on the global Inflammatory Bowel Disease Treatment market?

For more information or a query or a personalization before purchasing, visit @ https://www.marketresearchintellect.com/product/global-inflammatoire-intestinal-disease-traitement-market-size-and-forecast/

The study thoroughly explores the profiles of the major market players and their main financial aspects. This comprehensive business analyst report is useful for all existing and new entrants when designing their business strategies. This report covers the production, revenue, market share and growth rate of the Inflammatory Bowel Disease Treatment market for each key company, and covers the breakdown (production, consumption, revenue and market share) by regions, type and applications. Historical Inflammatory Bowel Disease Treatment Breakdown Data from 2016 to 2020 and Forecast to 2021-2029.

About Us: Market Research Intelligence

Market Research Intellect provides syndicated and personalized research reports to clients from various industries and organizations in addition to the goal of providing personalized and in-depth research studies. range of industries, including energy, technology, manufacturing and construction, chemicals and materials, food and beverage. Etc. Our research studies help our clients make more data-driven decisions, admit push predictions, grossly capitalize on opportunities, and maximize efficiency by acting as their criminal belt to adopt accurate mention and essential without compromise. clients, we have provided expertly-behaved affirmation research facilities to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi.

Contact us:
Mr. Edwyne Fernandes
United States: +1 (650) -781-48080
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

Website: –https://www.marketresearchintellect.com/

]]>
Ono Pharmaceutical Co., Ltd. – Opdivo intravenous infusion approved for adjuvant treatment of esophageal cancer or gastroesophageal junction cancer in Taiwan https://gut-training.com/ono-pharmaceutical-co-ltd-opdivo-intravenous-infusion-approved-for-adjuvant-treatment-of-esophageal-cancer-or-gastroesophageal-junction-cancer-in-taiwan/ Thu, 06 Jan 2022 14:56:16 +0000 https://gut-training.com/ono-pharmaceutical-co-ltd-opdivo-intravenous-infusion-approved-for-adjuvant-treatment-of-esophageal-cancer-or-gastroesophageal-junction-cancer-in-taiwan/ Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Chairman, Deputy Director, Gyo Sagara; ‘ONO’) announced that Ono Pharma Taiwan Co., Ltd. (“OPTW”), a Taiwanese subsidiary of ONO, has received additional approval from Opdivo (nivolumab) Intravenous Infusion 20 mg, 100 mg Inj. (“Opdivo”), a human anti-human PD-1 monoclonal antibody, on December 29, 2021 in Taiwan from Taiwan Food […]]]>

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Chairman, Deputy Director, Gyo Sagara; ‘ONO’) announced that Ono Pharma Taiwan Co., Ltd. (“OPTW”), a Taiwanese subsidiary of ONO, has received additional approval from Opdivo (nivolumab) Intravenous Infusion 20 mg, 100 mg Inj. (“Opdivo”), a human anti-human PD-1 monoclonal antibody, on December 29, 2021 in Taiwan from Taiwan Food and Drug Administration (TFDA) for the adjuvant treatment of patients with completely resected esophageal cancer or gastroesophageal junction cancer with residual pathologic disease who have received concomitant neoadjuvant chemoradiotherapy.

This approval is based on the result of a global, multicenter, randomized, double-blind, phase 3 clinical study, Study CheckMate -577 (ONO-4538-43), evaluating Opdivo as monotherapy as adjuvant therapy in patients with d ‘resected esophageal cancer or cancer of the gastroesophageal junction, compared to placebo. In this study, Opdivo showed a statistically significant improvement in disease-free survival (DFS), the primary endpoint of the study, compared to placebo. The safety profile of Opdivo in this study was consistent with previously reported studies of Opdivo as monotherapy.

About the CheckMate -577 study (ONO-4538-43)

The CheckMate -577 study is a global, multicenter, randomized, double-blind, phase 3 clinical study evaluating Opdivo as monotherapy as adjuvant therapy in patients with resected esophageal cancer (ESC) or cancer of the gastroesophageal junction (CJGE) who received neoadjuvant radiochemotherapy (CRT) and did not obtain a complete pathological response. After neoadjuvant CRT and complete surgical resection of the tumor (also known as trimodal therapy), patients were randomized to receive Opdivo or placebo. In patients receiving Opdivo, it was given 240 mg every two weeks for 16 weeks, followed by Opdivo 480 mg every four weeks until disease recurrence, unacceptable toxicity or withdrawal of consent, with maximum total treatment time of one year. The primary endpoint of the study is disease-free survival (SSM) and the secondary endpoint is overall survival (OS).

About cancer of the esophagus and cancer of the gastroesophageal junction

Esophageal cancer (ESC) is a malignant tumor that occurs in the inner layer (lining) of the esophagus and grows outside (towards the deeper layer). There are two main histological types of CSE; Squamous cell carcinoma (SCC) and adenocarcinoma. SCC is the predominant type accounting for about 90% of all ESCs in Taiwan. It is estimated that approximately 2,800 new cases 1) are diagnosed with ESC per year in Taiwan and about 1,900 deaths 1) per year from this disease. Gastroesophageal junction cancer (GEJC) is a malignant tumor that occurs in the area of ​​the body that connects the lower part of the esophagus to the stomach 2).?

Cancer Registry Annual Report, 2018 Taiwan

American Cancer Society. What is esophageal cancer?

About Opdivo

Opdivo is a programmed death immune checkpoint-1 (PD-1) inhibitor designed to uniquely harness the body’s own immune system to help restore the anti-tumor immune response by blocking the interaction between PD-1 and its ligands. By harnessing the body’s immune system to fight cancer, Opdivo has become an important treatment option for several cancers since the approval of melanoma treatment in Japan in july 2014. Opdivo is currently approved in more than 65 countries, including Japan, South Korea, Taiwan, China, the we and European Union.

In Japan, ONO launched Opdivo for the treatment of unresectable melanoma in september 2014. Subsequently, Opdivo received approval for additional indications of unresectable, advanced or recurrent non-small cell lung cancer in december 2015, unresectable or metastatic renal cell carcinoma in august 2016, relapsed or refractory classic Hodgkin lymphoma in december 2016, recurrent or metastatic head and neck cancer in march 2017, advanced or recurrent unresectable gastric cancer that has progressed after chemotherapy in september 2017, unresectable advanced or recurrent malignant pleural mesothelioma that has progressed after chemotherapy in august 2018, and advanced or recurrent unresectable microsatellite instability (MSI-High) colorectal cancer that has progressed after chemotherapy and advanced or recurrent unresectable esophageal cancer that has progressed after chemotherapy in February 2020, and cancer of unknown primary in december 2021.

In addition, ONO has submitted an additional application for adjuvant treatment of urothelial cancer and is conducting a clinical development program including hepatocellular carcinoma, ovarian cancer, bladder cancer, prostate cancer, cancer of the pancreas, cancer of the bile ducts, etc.

About the ONO and Bristol Myers Squibb collaboration

In 2011, thanks to a collaboration agreement with Bristol Myers Squibb (BMS), ONO has granted BMS its territorial rights to develop and market Opdivo globally, except in Japan, South Korea and Taiwan, where ONO had retained all rights to Opdivo with the exception of the United States at the time. In july 2014, ONO and BMS have further expanded their strategic collaboration agreement to jointly develop and market several immunotherapies – in monotherapy and in combination – for cancer patients in Japan, South Korea and Taiwan.

On Ono Pharma Taiwan Co., Ltd.

Ono Pharma Taiwan Co., Ltd. (Taipei, Taiwan, “OPTW”) is a 100% subsidiary of ONO established in december 2014. OPTW has established its own sales organization in Taiwan and has marketed Opdivo, an anti-PD-1 antibody / anti-neoplastic drug since 2016. OPTW is committed to providing new, more innovative products to meet the unmet medical needs of patients in Taiwan as soon as possible.

Contact:

ONO PHARMACEUTICAL CO., LTD.

Business communication

E: public_relations@ono.co.jp

]]>
Constipation Treatment Market Size, Trends, Forecast to 2029 https://gut-training.com/constipation-treatment-market-size-trends-forecast-to-2029/ Tue, 04 Jan 2022 21:03:21 +0000 https://gut-training.com/constipation-treatment-market-size-trends-forecast-to-2029/ New Jersey, United States, – the Constipation Treatment Market is thoroughly researched in the report, primarily focusing on the major players and their business tactics, geographic expansion, market segments, competitive landscape, manufacturing, and price and cost structure. Each section of the study is specially prepared to examine key aspects of the Constipation Treatment market. For […]]]>

New Jersey, United States, – the Constipation Treatment Market is thoroughly researched in the report, primarily focusing on the major players and their business tactics, geographic expansion, market segments, competitive landscape, manufacturing, and price and cost structure. Each section of the study is specially prepared to examine key aspects of the Constipation Treatment market. For example, the Market Dynamics section delves into the drivers, restraints, trends, and opportunities in the Constipation Treatment market. With qualitative as well as quantitative analysis we help you with in-depth and comprehensive research on the Constipation Treatment market. We also focused on the SWOT, PESTLE, and Porter’s Five Forces analysis of the Constipation Treatment market.

The major players of the Constipation Treatment market are analyzed keeping in view their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide exhaustive analysis of their product portfolios to explore the products and applications they focus on when operating in the Constipation Treatment market. Further, the report offers two distinct market forecasts – one for the production side and another for the consumption side of the Constipation Treatment market. It also provides useful recommendations for new and established players in the Constipation Treatment market.

Get sample full PDF copy of report: (including full table of contents, list of tables and figures, graph) @ https://www.verifiedmarketresearch.com/download-sample/?rid=29799

Key Players Mentioned in the Constipation Treatment Market research report:

Takeda Pharmaceutical Company Ltd., Synergy Pharmaceuticals Abbott Laboratories, AstraZeneca, Bayer AG.

Constipation Treatment Market Segmentation:

Constipation Treatment Market, By Disease Type

• Chronic idiopathic constipation (CIC)
• Irritable bowel syndrome with constipation (IBS-C)
• Opioid induced constipation (OIC)

Constipation Treatment Market, By Treatment Option

• Laxatives
• Chloride channel activators
• Peripherally acting mu-opioid receptor antagonists
• GC-C agonists
• 5-HT4 receptor agonists

Constipation Treatment Market, By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

The Constipation Treatment market is segmented on the basis of product type, application, and geography. All of the segments of the Constipation Treatment market are carefully analyzed on the basis of their market share, CAGR, growth in value and volume, and other significant factors. The report also provides precise estimates on the CAGR, revenue, production, sales, and other calculations for the Constipation Treatment market. Each regional market is extensively studied in the report to explain why some regions are growing at a high pace while others are growing at a low pace. We have also provided Porter’s Five Forces Analysis and PESTLE for further study of the Constipation Treatment market.

Get a discount on purchasing this report @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=29799

Scope of Constipation Treatment Market Report

ATTRIBUTES DETAILS
ESTIMATED YEAR 2022
YEAR OF REFERENCE 2021
PLANNED YEAR 2029
HISTORICAL YEAR 2020
UNITY Value (million USD / billion)
COVERED SEGMENTS Types, applications, end users, etc.
REPORT COVER Revenue forecast, company ranking, competitive landscape, growth factors and trends
BY REGION North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
CUSTOMIZATION SCOPE Free customization of the report (equivalent to 4 working days for analysts) with purchase. Add or change the scope of country, region and segment.

Geographic segment covered in the report:

The Constipation Treatment report provides information about the market area, which is further subdivided into sub-regions and countries / regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country and sub-region during the estimated period.

• North America (United States and Canada)
• Europe (UK, Germany, France and rest of Europe)
• Asia-Pacific (China, Japan, India and the rest of the Asia-Pacific region)
• Latin America (Brazil, Mexico and the rest of Latin America)
• Middle East and Africa (GCC and rest of Middle East and Africa)

Key questions answered in the report:

1. Who are the dominant players in the Constipation Treatment market?

2. How will the constipation treatment market evolve over the next five years?

3. Which product and application will capture the lion’s share of the Constipation Treatment market?

4. What are the drivers and restraints of the Constipation Treatment market?

5. Which regional market will show the most growth?

6. What will be the CAGR and size of the Constipation Treatment market throughout the forecast period?

For more information or a query or a personalization before purchasing, visit @ https://www.verifiedmarketresearch.com/product/constipation-traitement-market/

Visualize the Constipation Treatment Market Using Verified Market Intelligence: –

Verified Market Intelligence is our BI platform for narrative storytelling for this market. VMI offers in-depth forecasting trends and accurate insight into over 20,000 emerging and niche markets, helping you make critical revenue-impacting decisions for a bright future.

VMI provides a holistic overview and global competitive landscape with regard to region, country and segment, and key players in your market. Present your market report and findings with a built-in presentation function, saving over 70% of your time and resources for investor arguments, sales and marketing, R&D and product development. VMI enables data delivery in interactive Excel and PDF formats with over 15+ key market indicators for your market.

Visualize the Constipation Treatment Market Using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/

About Us: Verified Market Research®

Verified Market Research® is a leading global research and consulting company providing advanced analytical research solutions, personalized advice and in-depth data analysis for over 10 years to individuals and businesses seeking precise research, reliable and up to date. technical data and advice. We provide insights into strategic and growth analysis, the data needed to meet business goals and help make critical revenue decisions.

Our research studies help our clients make superior data-driven decisions, understand market forecasts, capitalize on future opportunities, and optimize efficiency by working as a partner to deliver accurate and valuable information. The industries we cover cover a broad spectrum including technology, chemicals, manufacturing, energy, food and beverage, automotive, robotics, packaging, construction, mining and manufacturing. gas. Etc.

At Verified Market Research, we help understand holistic factors indicating the market and most current and future market trends. Our analysts, with their deep expertise in data collection and governance, use industry techniques to gather and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject matter expertise, and years of collective experience to produce informative and accurate research.

After serving over 5,000 clients, we have provided reliable market research services to over 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the world’s largest consulting firms such as McKinsey & Company, Boston Consulting Group, Bain and Company for personalized research and consulting projects for businesses around the world.

Contact us:

Mr. Edwyne Fernandes

Verified Market Research®

United States: +1 (650) -781-48080
UK: +44 (753) -715-0008
APAC: +61 (488) -85-9400
US Toll Free: +1 (800) -782-1768

E-mail: [email protected]

Website:- https://www.verifiedmarketresearch.com/

]]>
Schistosomiasis Treatment Market Detailed in New 2022 Research Report | Chemos GmbH & Co. KG, Shin Poong Pharma.Co. Ltd. https://gut-training.com/schistosomiasis-treatment-market-detailed-in-new-2022-research-report-chemos-gmbh-co-kg-shin-poong-pharma-co-ltd/ Mon, 03 Jan 2022 12:58:00 +0000 https://gut-training.com/schistosomiasis-treatment-market-detailed-in-new-2022-research-report-chemos-gmbh-co-kg-shin-poong-pharma-co-ltd/ Treatment of schistosomiasis SEATTLE, WASHINGTON, UNITED STATES, January 3, 2022 /EINPresswire.com/ – SCHISTOSOMIASIS TREATMENT MARKET TO ANALYSE Schistosomiasis is a disease caused by a disease caused by parasitic freshwater worms. It may very well be an intense or persistent disease caused in large part by blood accidents of parasitic worms (trematode worms). There are two […]]]>

Treatment of schistosomiasis

SEATTLE, WASHINGTON, UNITED STATES, January 3, 2022 /EINPresswire.com/ – SCHISTOSOMIASIS TREATMENT MARKET TO ANALYSE

Schistosomiasis is a disease caused by a disease caused by parasitic freshwater worms. It may very well be an intense or persistent disease caused in large part by blood accidents of parasitic worms (trematode worms). There are two types of schistosomiasis, for example, gastrointestinal and urogenital. According to World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for HIV transmission in women. People are usually contaminated during agro-industrial, domestic and professional activities, which exposes them to contaminated water and safe responses. Indications in patients with gastrointestinal schistosomiasis show different manifestations, for example, stomach upset, discharge, enlarged liver and spleen, bladder fibrosis and moderate kidney damage. Other ongoing manifestations are reminiscent of blood in stool, blood in urea, genital sores, vulva, convulsions, loss of movement, blisters, and vaginal death. These indications could lead to complications from urogenital schistosomiasis, such as bladder disease, and long-term irreversible outcomes such as infertility. According to the World Health Organization (WHO), around 218 million people needed preventive treatment for schistosomiasis in 2015, and more than 66.5 million people were treated for schistosomiasis at around the same time. . In addition, the WHO indicates that transmission of schistosomiasis has been recorded in 78 countries. Treatment of schistosomiasis is a central problem due to the lack of appropriate drugs and inoculation. Preventive chemotherapy for schistosomiasis includes praziquantel, metrifonate, and oxamniquine.

𝐆𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐇𝐞𝐫𝐞 @ https://www.coherentmarketinsights.com/insight/request-pdf/889

Advancement of New Antibodies for Treatment of Schistosomiasis Used to Drive Development of Schistosomiasis Treatment Market

According to the University of Nottingham in 2017, scientists found the infiltrating protein on a parasitic egg, which could be responsible for this irresistible disease. This disclosure normally establishes open doors for the designated advancement of vaccination and treatment. Additionally, the College of Science at Oregon State University (OSU) discovered the new protein in the snail Biomphalaria glabrata, known as Grctm6 in 2017. Research is ongoing to use this protein as a specialist. of the biological control of schistosomiasis.

Dr Afzal Siddiqui, educator at Tech Health Sciences Center, in 2015 obtained a patent for vaccination against schistosomiasis. The antibody has won preclinical preliminaries and goes through clinical preliminaries for the assessment of well-being and viability. Patent applications have also been registered in China, India and Brazil. Dr Siddiqui intends to create and disperse this antibody at rates reasonable for infected individuals. It is being used to boost the development of the schistosomiasis treatment market in the future.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/889

Growing interest in schistosomiasis chemoprevention cited to lean towards market development for schistosomiasis treatment

According to the World Health Organization (WHO) in 2017, around 92% of people need preventive chemotherapy for schistosomiasis in Africa. About 75% of school-aged children are at risk of sadness due to schistosomiasis and soil-borne helminthiasis. In addition, 78% of economies experience an episode of schistosomiasis and 52% of these countries require chemoprevention. Additionally, according to WHO reports, globally 207.7 million people required preventive chemotherapy in 2016, of which around 111.8 million were school-aged children. The expanding prevalence of schistosomiasis and its entanglements is an important driving force that would fuel the development of the schistosomiasis treatment market in the not-so-distant future. The lack of emerging economies of a clean climate and safe drinking water is cited to boost the development of the schistosomiasis market.

In May 2017, the Global Schistosomiasis Alliance coordinated the Global Neglected Tropical Infections (NTDs) program facilitated by the World Health Organization (WHO). Many associations from different economies have supported this schistosomiasis control program, which integrates the Chinese Centers for Disease Control and Prevention (CDC), Research for Control and Elimination (SCORE), the Tropical Institute and of Swiss Public Health, the Federal Ministry of Health Ethiopia (FMHE) and the Ministry of Health (MoH).

The major players in the schistosomiasis treatment market include Egyptian International Pharmaceuticals Industries Co SAE (EIPICO), Taj Pharmaceuticals Ltd., Samarth Pharma Pvt. Ltd., VHB Life Science Inc., CBC Pharma., Avanscure Lifesciences Pvt. Ltd, aj Pharmaceuticals Ltd., 3S Corporation Kancera AB, LondonPharma Ltd, Merck & Co., Inc., Bayer AG, Salvensis, Merck & Co., Meher Distributors Pvt. Ltd., Shin Poong Pharma.Co. Ltd., and Chemos GmbH & Co. KG.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐥𝐚𝐭 𝟑𝟎% 𝐎𝐅𝐅;

𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐅𝐮𝐥𝐥 @ https://www.coherentmarketinsights.com/insight/buy-now/889

About Us:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, custom research reports, and advisory services. We are known for our actionable insights and authentic reports in a variety of fields including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually every field. and a comprehensive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reporting. We are also committed to playing a leading role in providing insight into various post-COVID-19 sectors and continue to deliver measurable and sustainable results to our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn
Other

]]>
Man who raffled his car to pay for cancer treatment gets it back from winner https://gut-training.com/man-who-raffled-his-car-to-pay-for-cancer-treatment-gets-it-back-from-winner/ Fri, 31 Dec 2021 17:48:03 +0000 https://gut-training.com/man-who-raffled-his-car-to-pay-for-cancer-treatment-gets-it-back-from-winner/ Cancer patient raffled off in his car to pay for cancer treatment has the chance to pick up winner’s car The raffle winner thought it wise to return the car to the original owner despite winning it in a fair draw The man who won the raffle was seen handing over vehicle documents to the […]]]>
  • Cancer patient raffled off in his car to pay for cancer treatment has the chance to pick up winner’s car
  • The raffle winner thought it wise to return the car to the original owner despite winning it in a fair draw
  • The man who won the raffle was seen handing over vehicle documents to the man in an encouraging video

To pay the hospital bills he incurred to treat cancer, a Mexican had his car raffled off. He was lucky because the man who won the raffle decided to be human enough to return the car to him.

The man bringing documents into his car. Credit: Good News Movement
Source: Instagram

A video shared on Instagram by Good News Movement showed the happy moment when the man picked up his vehicle in the presence of jubilant people. According to the good news movement:

Read also

Wife pays off her husband’s student loan debt, man is on the verge of tears in the video, hugs her

PAY ATTENTION: Install our last application for Android, read the best news on Nigeria’s # 1 news app

“A man in Mexico raffled his Chevy truck to pay for stomach cancer treatment. He never expected the car to be returned to him.”

Internet users react

Internet users who have seen the inspirational video have this to say:

@___vandrade:

“My husband says I cry too much when I come to this page and he is absolutely right.”

@intotheevening:

“It’s not nice. It’s devastating. We are failing our health care system and there is nothing cute about it.”

@kalikat:

“Beautiful people and goodwill among men, but he should never have worried about paying for cancer treatment in the first place. It is absolutely criminal for a country to do this to its citizens.”

@eliseazkoul:

“Absolutely beautiful act of kindness. Showing love to others when it matters most. God bless these humans and all who are struggling like this right now. Prayers for love and healing.”

Read also

Who else goes shopping? People call each other as Omah Lay pays for those shopping in Port Harcourt Mall

@kymdouglas:

“He’s the best they are yet, they’re a few good people in this world, we just can’t see them in the media.”

See the heartwarming video below:

Young worker returns lost phone to owner

In a related story also reported by Legit.ng a young man returned a lost phone to the owner and was praised for his act of kindness.

The amiable man, identified as Nduduzo Dlamini, found the lost phone at an amusement park, but decided to return it right away instead of keeping it to himself.

Nduduzo Dlamini, a South African, received praise for his honesty as netizens described him as nothing but a Good Samaritan.

Source: Legit.ng

]]>
What is cytomegalovirus Symptoms, infection and treatment explained https://gut-training.com/what-is-cytomegalovirus-symptoms-infection-and-treatment-explained/ Thu, 30 Dec 2021 12:07:31 +0000 https://gut-training.com/what-is-cytomegalovirus-symptoms-infection-and-treatment-explained/ The U.S. Centers for Disease Control and Prevention (CDC) has advised people to be wary of cytomegalovirus (CMV) during the holiday season. CMV is a virus common in people of all ages that is usually not harmful, although it is associated with birth defects in babies born with it. Nearly one in three children in […]]]>

The U.S. Centers for Disease Control and Prevention (CDC) has advised people to be wary of cytomegalovirus (CMV) during the holiday season.

CMV is a virus common in people of all ages that is usually not harmful, although it is associated with birth defects in babies born with it.

Nearly one in three children in the United States is already infected by the age of 5, and more than half of adults have it by the age of 40, according to the CDC.

Once a person is infected with CMV, they carry the virus for life. Most people with CMV have no symptoms and may not even know they have the virus at all. The immune system of a healthy person usually stops the virus from causing disease, says the CDC.

When symptoms appear, healthy people may experience fever, sore throat, fatigue, swollen glands, or muscle pain, according to the CDC and Mayo Clinic.

However, in people with weakened immune systems, CMV can cause more serious symptoms that can affect the eyes, lungs, liver, esophagus, stomach, and intestines.

Additionally, babies born with CMV can have problems with the brain, liver, spleen, lung, and growth, a common problem being hearing loss. The CDC says CMV is the most common infectious cause of birth defects in the United States, and one in five babies born with this virus will have birth defects or other long-term health problems.

CMV is transmitted through bodily fluids such as saliva, urine, blood, tears, semen, and breast milk. As such, it can be transferred between people through contact with saliva or urine, through sexual contact, through breastfeeding, or through organ transplantation or blood transfusion. It can be diagnosed by a blood, urine or saliva test.

According to the UK’s National Health Service (NHS), CMV is transmitted when it is ‘active’, such as when someone first catches it (children often get it in nurseries) or when ‘they get reinfected with a different variant, or when reactivated in the body due to a weakened immune system. Pregnant women can pass an “active” CMV infection to their unborn baby.

CMV can sometimes go from an active stage to a dormant stage, although in healthy people it usually stays dormant, according to the Mayo Clinic.

In a tweet published on Wednesday, the CDC said people can avoid CMV by not sharing cups or other items that may contain saliva.

Additionally, the Mayo Clinic states that people should be careful with their hygiene, such as avoiding kissing a child on the lips, “especially important if you are pregnant.” It is also advisable to wash your hands often and well with soap and water for 15 to 20 seconds.

You can find more information about prevention on the CDC and Mayo Clinic websites.

Treatments are available for people with CMV, although healthy people usually do not need them.

Babies with CMV at birth, for example, may benefit from antiviral drugs like valganciclovir that can improve developmental outcomes, says the CDC, although this can have serious side effects.

Research is underway to characterize the impact of CMV on various populations and to assess long-term outcomes in children born with it.

Moderna CEO Stéphane Bancel previously said News week that Moderna considered developing a vaccine against CMV.

An archive photo shows someone washing their hands. The Mayo Clinic says that careful personal hygiene, such as washing your hands thoroughly with soap and water and avoiding contact with saliva, can help reduce the risk of spreading CMV.
Alex Raths / Getty
]]>
First Dates star Merlin provides update on his ‘horrific’ cancer treatment https://gut-training.com/first-dates-star-merlin-provides-update-on-his-horrific-cancer-treatment/ Thu, 30 Dec 2021 10:15:35 +0000 https://gut-training.com/first-dates-star-merlin-provides-update-on-his-horrific-cancer-treatment/ First Dates star Merlin Griffiths provided an update on his cancer treatment and detailed his “horrible” chemotherapy. The TV favorite, 46, revealed in September that he had been diagnosed with bowel cancer. And now he’s shared an update with the fans. Well there is a new #Cancer side effect… Months of chemo messed up my […]]]>

First Dates star Merlin Griffiths provided an update on his cancer treatment and detailed his “horrible” chemotherapy.

The TV favorite, 46, revealed in September that he had been diagnosed with bowel cancer.

And now he’s shared an update with the fans.

What did First Dates star Merlin say about his condition?

Speaking to Twitter, Merlin said, “Well there’s a new side effect of #cancer… months of chemo messed my hands up, now my phone refuses to recognize my biometric fingerprints! [cry-laugh emoji]. “

It was then that fans got in touch to share their own experiences and offer their support.

A fan contacted to sympathize and sympathize with Merlin.

Read more: First dates at Christmas: How is bartender Merlin Griffiths doing after his bowel cancer diagnosis?

Gillian said, “Gave me pins and needles in my hands and they burn in the bath?” “

Merlin then replied, “Neuropathy. I had that too!

“Luckily I quit IV chemo now, found it horrible, knocked me out for six.”

Merlin on the show (Credit: Channel 4)

What did the fans say in support?

Following Merlin’s update, fans also sent their support for the First Dates bartender.

One of them said, “I didn’t know you were going through that Merlin. I am so sorry you are a joy. Sending love for a speedy recovery x “

Another added: Merlin I wish you and yours all the happiness of the holidays [red heart emoji]

“Getting into your applications is underestimated. You are an absolute joy to watch on the first dates, thank you for your beautiful energy. I wish you good luck in your fight against cancer.

A third wrote: “Hi Merlin, I just want to wish you all the best for a good #topbarman recovery mate.”

Finally, a fourth fan said, “Oh, I’m sorry to read this, hope the processing works x.”

Merlin Griffiths First Dates Hotel
Merlin works his magic behind the bar on First Dates Hotel (Credit: Channel 4)

What was Merlin diagnosed with?

Merlin broke the news after complaining of bloating and nausea.

After x-rays, CT scans and sigmoidoscopy, a stage 3 tumor of 4.5 cm was found in her lower intestine.

Read more: First Dates star Merlin Griffiths reveals bowel cancer diagnosis and sensitive conversation with 7-year-old daughter

However, it had not spread and Merlin started chemotherapy treatment.

Doctors told the star he has a 75% chance of living more than five years.

Leave us a comment on our Facebook page @EntertainmentDailyFix and tell us what you think of this story.

]]>
East Ayrshire health bosses apologize for ‘failures’ in tragic treatment of cancer patient https://gut-training.com/east-ayrshire-health-bosses-apologize-for-failures-in-tragic-treatment-of-cancer-patient/ Mon, 27 Dec 2021 16:35:00 +0000 https://gut-training.com/east-ayrshire-health-bosses-apologize-for-failures-in-tragic-treatment-of-cancer-patient/ Senior Officers of the East Ayrshire Health and Social Care Partnership have apologized to the family of a cancer patient who died after ‘failures’ were made in monitoring their treatment at a local doctor’s office . The Scottish Public Services Ombudsman (SPSO) upheld a complaint against the NHS Ayrshire & Arran by the spouse of […]]]>

Senior Officers of the East Ayrshire Health and Social Care Partnership have apologized to the family of a cancer patient who died after ‘failures’ were made in monitoring their treatment at a local doctor’s office .

The Scottish Public Services Ombudsman (SPSO) upheld a complaint against the NHS Ayrshire & Arran by the spouse of the deceased patient.

Now the bosses of the partnership have admitted that they “failed to meet” the high standards they “strive for” in relation to the tragedy, which saw blood test results “outside the normal range. “pass” unrecognized “.

Essentially, earlier action should have been taken when blood test results were known and then compared to the patient’s history and symptoms.

The patient, known only as “A” and his spouse, known only as “C” have not been identified.

The location of the medical practice has not been disclosed, but it is within the NHS limits of Ayrshire and Arran.



The Ayrshire Live app is available for download now.

Get all the local news in your area – plus features, football news and the latest information on the coronavirus crisis – right at your fingertips 24/7.

The free download features the latest breaking news and exclusive stories, while you can customize your page with the sections that interest you.

The Ayrshire Live app is available for download now at ios and Android.

In its report, the SPSO said: “C complained that the firm failed to take reasonable action in response to the symptoms and condition of her late spouse (A).

“A had a long history of degenerative disc disease affecting her spine (when normal changes that occur in the discs in your spine cause pain) and a history of stomach cancer.

“A visited or contacted the practice several times in three months regarding neck and shoulder pain, numbness in right hand and twitching in right leg.

“Tests were carried out, drugs and therapies prescribed and a referral to an orthopedic specialist (a specialist in the treatment of diseases and injuries of the musculoskeletal system) was made.

“After a fall at home, A was admitted to a hospital where A was diagnosed with spreading cancer to A’s spine.”

The report goes on to say that the patient died, prompting her spouse to complain about the doctor’s office response to symptoms and A’s condition in the previous months.

The report states: “In response, the practice recounted the actions it had taken in response to A’s visits and contacts during her final months, found blood tests the results of which showed no evidence. significant abnormality or spread of cancer and explained that A’s symptoms were related to their ongoing diagnosis of degenerative cervical disc and spinal stenosis (a condition where the space around the spinal cord narrows, compressing a section of nerve tissue ).

“Practice has indicated that an important case review has been carried out. This had highlighted that A’s orthopedic orientation could have been upgraded to an emergency when it was clear A’s symptoms were not being controlled, but said it was doubtful that this had an impact on the result. C was not satisfied with this response and filed his complaint with this office.

During the SPSO investigation, they sought independent advice from a general practitioner.

An excerpt from the report reads: “We found that the firm was taking reasonable steps in response to A’s symptoms and condition – to some extent. However, when it became evident that A’s symptoms were not being controlled and started to get worse, the practice’s actions were unreasonable.

“We found that the potential significance of the test results reported to the office and the potential link to A’s symptoms were not reasonably recognized by the office until they reviewed A’s care and treatment at the office. following our investigation of the case.

“Therefore, we upheld C.

“However, although we noted that earlier practice action may have led to an earlier admission to hospital, it was extremely unlikely that it prevented A’s death.”

The medical practice at the center of the case has now been ordered to “revise” the way it treats blood samples that are “considerably outside the normal range.”

Craig McArthur, Director of the East Ayrshire Health and Social Services Partnership, said: ‘I am sorry we did not meet the high standards of care that we seek in the NHS Ayrshire & Arran for this patient, and I offer my deepest condolences to their families.

“In addition to a formal apology to A’s spouse, I can inform you that the GP practice has fully accepted all of the recommendations of the Scottish Public Services Ombudsman (SPSO) report.

“The practice of the general practitioner has resolved the identified issues and made the appropriate changes in terms of ensuring that all blood results are effectively communicated to patients, record keeping and required follow-up actions are carried out to required standards. and reviewing home visiting policies that have been updated in accordance with required guidelines.

He added, “To ensure learning across the organization, we will share the findings of the report with staff and reassurance to our clinical governance teams that the necessary actions have been taken. “

Don’t miss the latest Ayrshire titles –sign up for our free daily newsletter here

]]>
FDA Says Ivermectin Not a COVID Treatment, Warns of Dangers | Local News I Racine County Eye https://gut-training.com/fda-says-ivermectin-not-a-covid-treatment-warns-of-dangers-local-news-i-racine-county-eye/ Fri, 24 Dec 2021 19:36:03 +0000 https://gut-training.com/fda-says-ivermectin-not-a-covid-treatment-warns-of-dangers-local-news-i-racine-county-eye/ The United States Food and Drug Administration (FDA) has warned doctors and pharmacists nationwide against the use of the drug ivermectin in the treatment or prevention of COVID-19. In separate letters to the heads of the Federation of State Medical Boards and the National Association of Pharmacy Boards, Shannon N. Glueck, acting chief of branch […]]]>
]]>
Brazilian legend Pele, 81, discharged from hospital after treatment for colon tumor https://gut-training.com/brazilian-legend-pele-81-discharged-from-hospital-after-treatment-for-colon-tumor/ Thu, 23 Dec 2021 20:34:54 +0000 https://gut-training.com/brazilian-legend-pele-81-discharged-from-hospital-after-treatment-for-colon-tumor/ Brazilian legend Pele, 81, released from Sao Paulo hospital after undergoing chemotherapy sessions for colon tumor – with three-time World Cup winner ‘stable’ but expected to continue receiving treatment Pelé was treated in hospital after detecting colon tumor The all-time great footballer has now been released but will continue treatment Hospital statement confirmed 81-year-old legend […]]]>

Brazilian legend Pele, 81, released from Sao Paulo hospital after undergoing chemotherapy sessions for colon tumor – with three-time World Cup winner ‘stable’ but expected to continue receiving treatment

  • Pelé was treated in hospital after detecting colon tumor
  • The all-time great footballer has now been released but will continue treatment
  • Hospital statement confirmed 81-year-old legend is ‘stable’











Brazilian legend Pele was released from hospital in Brazil after undergoing chemotherapy sessions on a colon tumor – but will continue to receive treatment.

The 81-year-old man was treated at Albert Einstein Hospital in Sao Paulo, after the tumor was detected during routine examinations in late August.

“The patient is stable and will continue treatment for a colon tumor identified in September,” the hospital statement said.

Three-time World Cup winner Pelé was hospitalized in early December for a series of chemotherapy, but has now been cleared home.

He underwent surgery to remove the tumor in September, then spent almost a month in the hospital.

Pele released from hospital in Brazil after undergoing treatment for colon tumor

After keeping his social media followers updated on his progress, Pelé said on Twitter last month that he was “doing well” and “feeling better every day.”

In an Instagram post, the mercurial striker said he “had little chemotherapy sessions”, and added that he had just finished his last session of 2021.

“I wanted to share this success with you. After all, every little victory is a reason to celebrate, don’t you think? ‘ he wrote, with a picture of himself clenching his fist.

“Don’t worry, I’m just getting ready for the holiday season!” “

The all-time great returned to hospital for follow-up treatment (pictured with daughter Flavia)

The all-time great returned to hospital for follow-up treatment (pictured with daughter Flavia)

When he was taken to hospital earlier this month, he was described as being in stable condition and is expected to be released in the “next few days”.

It was also revealed that Pelé would “continue” his treatment.

After his admission, Pelé’s eldest daughter Kely Nascimento provided an update of hers – posting a photo of him smiling.

She wrote: “My sister Flavia Kurtz gives her a hug for me! In two or three days he is going home to enjoy Christmas.

Three-time World Cup winner Pelé is widely regarded as one of the best players in history

Three-time World Cup winner Pelé is widely regarded as one of the best players in history

“It wasn’t a surprise. It was already scheduled and is part of the treatment. All my gratitude, always.

However, Pelé’s health has been a source of concern in recent years.

He underwent prostate surgery in 2015 after being hospitalized for the second time in six months, and was admitted with a urinary tract infection in 2019.

Pelé won the World Cup in 1958, 1962 and 1070 – and remains Brazil’s all-time top scorer with 77 goals in 92 appearances.

Advertising

]]>